Rocket Lab rebound draws ARK buying as Neutron and Iridium deal drive outlook

  • Rocket Lab shares rose 3% to $71.98 as ARK Invest increased its position and CEO Peter Beck defended the proposed Iridium acquisition.
  • ARK bought 359,612 shares for approximately $25.1 million, lifting its holdings above 3.2 million shares valued near $225 million; Cantor retained an Overweight rating and $122 target.
  • Neutron is designed for approximately 13,000-kilogram payloads and $50 million-$55 million per mission, while the Iridium deal remains subject to approvals and is expected around mid-2027.

Rocket Lab shares rose 3% to $71.98 after ARK Invest bought 359,612 shares across three exchange-traded funds for approximately $25.1 million, bringing its holdings above 3.2 million shares valued near $225 million. CEO Peter Beck defended the proposed $8 billion cash-and-stock acquisition of Iridium Communications, saying its L-band spectrum cannot be replicated at any price. Cantor Fitzgerald reaffirmed an Overweight rating and a $122 price target, identifying Neutron’s first flight as the most material catalyst and saying the Iridium transaction could approximately double consolidated revenue. Neutron is designed to carry approximately 13,000 kilograms per flight, versus about 300 kilograms for Electron, with each mission expected to generate $50 million to $55 million. The Iridium transaction is expected to close around mid-2027 subject to regulatory approvals, while Neutron’s initial launch is targeted for the fourth quarter of 2026 but could slip into 2027 if qualification testing takes longer.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.